| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $20.2M | -1.6% |
| Cost of Revenue | $7.3M | +33.9% |
| R&D Expense | $1.4M | +2.6% |
| SG&A Expense | $12.5M | -8.0% |
| Operating Income | -$7.0M | -24.9% |
| Pre-tax Income | -$3.7M | -303.6% |
| Income Tax | $67K | -22.3% |
| Net Income | -$3.8M | -134.0% |
| EPS (Basic) | -$0.12 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.6M | -24.0% |
| Short-term Investments | $30.5M | -27.9% |
| Accounts Receivable | $4.0M | +54.4% |
| Current Assets | $44.5M | -22.4% |
| Total Assets | $47.2M | -19.9% |
| Current Liabilities | $16.6M | +142.8% |
| Total Liabilities | $17.1M | -47.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $283K | -61.2% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $17.3M | +142.8% |
| Financing Cash Flow | -$19.0M | -313.4% |
| Free Cash Flow | $283K | -56.7% |
| -135.3% |
| EPS (Diluted) | -$0.12 | -135.3% |
| Stockholders' Equity |
| $30.1M |
| +14.8% |